Cytotoxicity of triorganophosphinegold(I) n-mercaptobenzoates, n = 2, 3 and 4

Dick De Vos, Douglas R. Smyth, Edward R.T. Tiekink

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


The results of cytotoxicity trials against a panel of seven human cell lines for a series of triorganophosphinegold(I) 3- and 4-mercaptobenzoates are reported. While the new compounds show moderate to high toxicity, their potencies are inferior to those reported previously for their isomeric 2-mercaptobenzoate derivatives. The results therefore suggest a structure-activity relationship in that the 2-isomeric species are more active, particularly against the non-small cell lung cancer and renal cancer cell lines, results that may indicate some selectivity in their cytotoxic profile.

Original languageEnglish
Pages (from-to)303-306
Number of pages4
JournalMetal-Based Drugs
Issue number6
Publication statusPublished - 1 Jan 2001
Externally publishedYes

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Drug Discovery
  • Inorganic Chemistry

Cite this